11 Best Mid-Cap Value Stocks to Buy According to Analysts

9. H.B. Fuller Company (NYSE:FUL)

Fwd. P/E: 14.5

Potential Upside: 26%

Number of Hedge Fund Holders: 20

H.B. Fuller Company (NYSE:FUL) is a specialty chemicals manufacturer primarily focused on industrial adhesives. The company formulates, produces, and markets adhesives, sealants, and other specialty chemicals used across a wide range of industries worldwide.

H.B. Fuller Company (NYSE:FUL) is currently trading at a forward price-to-earnings (PE) ratio of 14.0, which is lower than its 12-month trailing PE of 24 and its historical average forward PE of 17. The company faced a weaker start to 2025 after lowering its Q4 2024 earnings guidance due to softer-than-expected market conditions and order delays. Additionally, planned price increases were postponed to 2025, while rising raw material costs further pressured profitability. For FY 2024, it reported adjusted EBITDA of $594 million and an adjusted EPS of $3.84.

To address these challenges, the company’s management is implementing cost-cutting measures and optimizing its manufacturing footprint through recently announced restructuring initiatives. As part of these efforts, H.B. Fuller Company (NYSE:FUL) has divested its Flooring business and introduced a reorganization across multiple business segments. Alongside these actions, the company is prioritizing margin expansion through portfolio transformation and operational efficiencies. It is also working to strengthen its position in the specialized adhesives market by gaining market share and accelerating growth through mergers and acquisitions. In line with this strategy, the company acquired two medical adhesive technology firms, GEM S.r.l. and Medifill Ltd, in late 2024.

Looking ahead, H.B. Fuller Company (NYSE:FUL) is projected to achieve earnings growth of 4% in the coming year, followed by a 15% increase, which would imply a forward PE of 12.